How Much Upside is Left in PAR Technology (PAR)? Wall Street Analysts Think 33.49%
ZACKS· 2025-06-05 15:02
PAR Technology (PAR) closed the last trading session at $65.46, gaining 6.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $87.38 indicates a 33.5% upside potential.The mean estimate comprises eight short-term price targets with a standard deviation of $10.27. While the lowest estimate of $65 indicates a 0.7% decline from the current price level, the most optimistic analyst expec ...
Does Natural Gas Services (NGS) Have the Potential to Rally 47.9% as Wall Street Analysts Expect?
ZACKS· 2025-06-05 15:02
Natural Gas Services (NGS) closed the last trading session at $24.51, gaining 27.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $36.25 indicates a 47.9% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $5.97. While the lowest estimate of $32 indicates a 30.6% increase from the current price level, the most optimistic analys ...
Wall Street Analysts Think LifeStance Health (LFST) Could Surge 45.04%: Read This Before Placing a Bet
ZACKS· 2025-06-05 15:02
LifeStance Health Group (LFST) closed the last trading session at $5.95, gaining 8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $8.63 indicates a 45% upside potential.The average comprises eight short-term price targets ranging from a low of $7 to a high of $10, with a standard deviation of $1.03. While the lowest estimate indicates an increase of 17.7% from the current price l ...
Wall Street Analysts See a 367.86% Upside in Verve Therapeutics (VERV): Can the Stock Really Move This High?
ZACKS· 2025-06-05 15:02
Verve Therapeutics (VERV) closed the last trading session at $5.29, gaining 25.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $24.75 indicates a 367.9% upside potential.The average comprises eight short-term price targets ranging from a low of $15 to a high of $39, with a standard deviation of $7.81. While the lowest estimate indicates an increase of 183.6% from the current pri ...
Does Synaptics (SYNA) Have the Potential to Rally 40.62% as Wall Street Analysts Expect?
ZACKS· 2025-06-05 15:02
Shares of Synaptics (SYNA) have gained 7.3% over the past four weeks to close the last trading session at $62.48, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $87.86 indicates a potential upside of 40.6%.The mean estimate comprises seven short-term price targets with a standard deviation of $11.85. While the lowest estimate of $80 indicates a 28% increase from the current pri ...
How Much Upside is Left in BioLife Solutions (BLFS)? Wall Street Analysts Think 41.72%
ZACKS· 2025-06-05 15:02
BioLife Solutions, Inc. (BLFS) closed the last trading session at $22.03, gaining 3.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $31.22 indicates a 41.7% upside potential.The average comprises nine short-term price targets ranging from a low of $30 to a high of $34, with a standard deviation of $1.48. While the lowest estimate indicates an increase of 36.2% from the current p ...
Wall Street Analysts See a 65.98% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High?
ZACKS· 2025-06-05 15:02
Benitec Biopharma Limited (BNTC) closed the last trading session at $15.49, gaining 14.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $25.71 indicates a 66% upside potential.The average comprises seven short-term price targets ranging from a low of $17 to a high of $35, with a standard deviation of $6.70. While the lowest estimate indicates an increase of 9.8% from the current ...
Wall Street Analysts See an 180.53% Upside in Knightscope (KSCP): Can the Stock Really Move This High?
ZACKS· 2025-06-05 15:02
Knightscope, Inc. (KSCP) closed the last trading session at $6.06, gaining 25.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $17 indicates an 180.5% upside potential.The mean estimate comprises three short-term price targets with a standard deviation of $11.36. While the lowest estimate of $9 indicates a 48.5% increase from the current price level, the most optimistic analyst e ...
Does Green Dot (GDOT) Have the Potential to Rally 29.63% as Wall Street Analysts Expect?
ZACKS· 2025-06-05 15:02
Green Dot (GDOT) closed the last trading session at $9.45, gaining 10.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $12.25 indicates a 29.6% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $2.06. While the lowest estimate of $10 indicates a 5.8% increase from the current price level, the most optimistic analyst expects th ...
Does Brainsway (BWAY) Have the Potential to Rally 43.88% as Wall Street Analysts Expect?
ZACKS· 2025-06-05 15:02
Brainsway Ltd. Sponsored ADR (BWAY) closed the last trading session at $10.46, gaining 20.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $15.05 indicates a 43.9% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $0.74. While the lowest estimate of $14.20 indicates a 35.8% increase from the current price level, the most optim ...